Latest filing published 26 Aug 2025 for Unicycive Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gaurav Aggarwal: trading record in brief
This profile gathers the share dealings of Gaurav Aggarwal across 5 companies, led by Sierra Oncology, Inc., Unicycive Therapeutics, Inc. and Ocera Therapeutics, Inc. Between 31 July 2012 and 25 August 2025, the trades on record add up to 12 filings.
No open-market sale appears; the market trades are 4 purchases worth €19.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants.
In size, the median ticket on the buying side is €32k.
Most recently, on 26 August 2025, the filings show a transaction in Unicycive Therapeutics, Inc. The clock since the last published purchase (31 January 2022) now reads 1,743 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gaurav Aggarwal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 652,900 sharesCommon StockSEC:0001213900-25-080808:0
- 1,400,000 sharesCommon StockSEC:0001213900-25-015152:0
- 5,500,000 sharesCommon StockSEC:0001213900-24-086928:0
- 1,970 shares0Common StockSEC:0001209191-24-000545:0
- 3,470,152 sharesCommon StockSEC:0001213900-23-056885:0
- 2,735,853 shares@ US$55.0085.2% of flowCommon StockSEC:0001209191-22-040279:0
- 800,000 shares@ US$27.0011.5% of flowCommon StockSEC:0001209191-22-005748:0Canonical exit: 1 May 2022 (T+90)
- 480,277 shares@ US$13.203.3% of flowCommon StockSEC:0001209191-22-005503:0
- 1,455,576 shares0Common StockSEC:0001209191-20-005792:0
- 10,000 shares@ US$2.15100.0% of flowCommon StockSEC:0001274644-16-000092:0Canonical exit: 14 Apr 2016 (T+90)
- 7,500 shares@ US$3.62Common StockSEC:0001274644-15-000032:0Canonical exit: 4 Aug 2015 (T+90)
- 5,000 shares@ US$10.00Common StockSEC:0001123292-12-000793:0Canonical exit: 29 Oct 2012 (T+90)
12 of 12 declarations